# Sources — Frances Burney

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Burney F. Journal letter to Esther Burney, March 22 to June 1812 ("A Mastectomy"). Public-domain text in a course transcription from the University of North Carolina Literature, Medicine, and Culture Colloquium; the manuscript is in the Henry W. and Albert A. Berg Collection, New York Public Library. Supports the onset "About August, in the year 1810" of "a small pain in my breast," "rather heavy than acute," increasing week by week; her reluctance to be examined and the months of treatment that followed; the increasing hardness; that "the poor breast was no where discoloured, and not much larger than its healthy neighbour"; that her right arm had been kept from use for many months; the operation at her home in Paris on "the last of September, 1811," by the surgeon Larrey, surgeon of the Imperial Guard, with other physicians and surgeons present; the wine cordial given beforehand; that the operation, including the dressing, "lasted 20 minutes"; that she believed she fainted twice; and that, nine months later, "the recollection is still so painful." https://lmcc.web.unc.edu/wp-content/uploads/sites/3253/2024/04/Burney-A-Mastectomy-1812.pdf
2. The Grub Street Project (University of Saskatchewan). "Frances Burney (1752–1840)." Supports her birth in King's Lynn, Norfolk, on June 13, 1752; her mother's death in 1762; *Evelina*, published anonymously in January 1778, and four novels between 1778 and 1814; her meeting Alexandre d'Arblay in 1793 and their marriage; the birth of her only child, Alexander, in December 1794; her move to France in April 1802; "the mastectomy for breast cancer, without anesthetic, that she endured in September 1811"; and her death on January 6, 1840. https://grubstreetproject.net/people/10163
3. Lippi D. "Fanny Burney's mastectomy: tuberculosis not carcinoma." *Vesalius* 2024;1:11–28. Title and abstract record only; the full argument was not read. Cited for the existence of the dispute (**R**). https://flore.unifi.it/handle/2158/1406436
4. Lush R. "I Thought I Must Have Expired – Experiences of Surgery Before Anaesthesia." *J Anesth Hist* 2020;6(2):35–37. PMID 32593374. Abstract only. It dates the operation to 1812 and says the letter was written in the days after surgery, both of which the letter itself contradicts, so it is cited only as context. https://pubmed.ncbi.nlm.nih.gov/32593374/
5. Brandt L, Artmeier-Brandt U. "Victory over surgical pain" [in German]. *Anaesthesist* 2016;65(10):727–745. PMID 27421850. Abstract supports the mastectomy without anesthesia on 30 September 1811. https://pubmed.ncbi.nlm.nih.gov/27421850/
6. Meek H. "Frances Burney's Mastectomy Narrative and Discourses of Breast Cancer in the Long Eighteenth Century." *Lit Med* 2017;35(1):27–45. PMID 28529229. Abstract supports the 1812 letter as a patient narrative. https://pubmed.ncbi.nlm.nih.gov/28529229/
7. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025. Diagnostic imaging and biopsy, receptor testing, optional breast MRI, no staging scans for early disease without symptoms, breast-conserving surgery or mastectomy, sentinel node biopsy, recurrence-score testing, and indications for radiation after mastectomy. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419
2. Bedrosian I, et al. "Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline." *J Clin Oncol* 2024. Testing for patients diagnosed at 65 or younger, ideally before surgery when it may change the operation. https://pubmed.ncbi.nlm.nih.gov/38175972/
3. Burstein HJ, et al. "Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update." *J Oncol Pract* 2019. An aromatase inhibitor for postmenopausal women. https://pubmed.ncbi.nlm.nih.gov/30523754/
4. Runowicz CD, et al. "American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline." *CA Cancer J Clin* 2016;66(1):43–73. https://pubmed.ncbi.nlm.nih.gov/26641959/
5. Khatcheressian JL, et al. "Breast Cancer Follow-Up and Management After Primary Treatment: ASCO Clinical Practice Guideline Update." *J Clin Oncol* 2013;31(7):961–965. https://pubmed.ncbi.nlm.nih.gov/23129741/
6. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), breast cancer monograph. History and examination every 3 to 6 months for years 1 to 3; yearly mammography of the remaining breast after mastectomy; no routine blood tests, tumor markers, or distant imaging without symptoms; on an aromatase inhibitor, a baseline DXA repeated every 2 years, calcium and vitamin D, lipid monitoring, and joint-pain review; lymphedema assessment and counseling at every visit; distress screening at intervals; vasomotor and sexual symptom review; lifestyle counseling; and a survivorship care plan. https://patrickrutledge.github.io/topthirty/
7. Stevens DL, et al. "Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America." *Clin Infect Dis* 2014. Used for the sick visit, to judge that the seroma was not infected. https://pubmed.ncbi.nlm.nih.gov/24947530/
8. Medicare Preventive Services reference (Aether Forge, 2026). The preventive visit template. https://patrickrutledge.github.io/preventative_services/
9. U.S. Preventive Services Task Force: A and B recommendations, colorectal cancer (2021), cervical cancer (2018), osteoporosis (2025), and statin use for primary prevention (2022). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
10. Centers for Disease Control and Prevention. Screening and Testing for Hepatitis B Virus Infection, 2023 (https://pubmed.ncbi.nlm.nih.gov/36893044/), and the Adult Immunization Schedule by Age (https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html).

## Editorial resolutions

- **Primary source.** The letter was read in full in a public-domain course transcription. Facts and short quotations are taken from it. The many statements the letter attributes to the surgeon, the other physicians, her husband, her son, and her friends are not used, so that no words or decisions are attributed to real people. The surgeon is named only as a documented fact. The contemporary diagnosis of cancer is not quoted from any physician.
- **Was it cancer?** Her letter calls the disease a cancer, and the Grub Street Project describes "the mastectomy for breast cancer." No tissue was examined, and a 2024 article argues that it was tuberculosis rather than carcinoma (only its title and abstract were read). She lived more than 28 years after the operation. The specific diagnosis is graded **R** with certainty disputed. The modern problem is linked to the documented illness and operation (**D**) and to the disputed interpretation (**R**), with placement both_with_link. It is marked confirmed only because biopsy and pathology confirm it within the synthetic episode.
- **Which breast.** The letter says her right arm had been kept from use for many months before the operation; it does not name the breast in the transcribed text. The synthetic episode uses the right breast, consistent with the arm and with common accounts, but the side is not asserted in a claim.
- **Dates of the letter.** The transcription heads the letter March 22 to June 1812, and the letter says it was begun about three months earlier and written nine months after the operation. One article abstract dates the operation to 1812 and the letter to the days after surgery; it is cited as context only.
- **Index age.** Burney was 59 at the operation. The modern episode presents her at 59, so the synthetic date of birth is June 13, 1967 (shift 215 years). The index visit on August 10, 2026 maps to August 10, 1811, about a year after the documented onset of breast pain. The synthetic mastectomy is dated September 30, 2026, which maps to the documented operation on September 30, 1811; this was chosen deliberately so that the true-date record does not contradict the documented date, and so that the modern operation under general anesthesia with a nerve block can be read beside her account. The other visits (August 24, October 8, October 19, and October 29, 2026) map to the same days of 1811. All fall within her lifetime and contradict no documented event.
- **Synthetic clinical picture.** The presenting heavy ache, the long delay, and the unchanged color and size of the breast echo the letter. Everything else is synthetic: the imaging, the two foci, receptors, recurrence score, stage, germline result, the seroma, the bone density, laboratory values, and the treatment. Her documented dread of the operation and her wish to be warned are echoed in the synthetic plan, which gives her advance notice of every step. Her late first and only birth (at 42) is documented and is recorded because it is a breast cancer risk factor.
- **Family history.** Only her mother's death in 1762 is recorded, with "cause not recorded in the cited source." Nothing is said about the health of her father, sisters, husband, or son. The synthetic notes describe her family history as too limited to be reassuring, which supports the germline testing.
- **Sick visit.** An unscheduled sick visit on October 8, 2026 (true frame October 8, 1811) for a seroma under the mastectomy flap, eight days after surgery and two days after drain removal. It is a common complication of the synthetic operation, does not echo a documented illness, and teaches the distinction between seroma and infection.
- **Preventive visit.** An adult preventive visit (age 59, so `preventive_adult`) on October 29, 2026 (true frame October 29, 1811), ten days after anastrozole began. Synthetic judgment calls: the colonoscopy eight years earlier and the cervical co-test three years earlier are recorded as normal history; hepatitis B, hepatitis C, and HIV screening are ordered with no results; the advance care planning names no real person as her health care agent.
- **Focused visits.** The two chronic-care follow-ups (two weeks after presentation, at diagnosis, and three weeks after surgery) are documented as focused visits on the NCCN breast cancer workup and the CMID breast cancer monograph. Each lists every item the protocol calls for at that point, with its interval and status, including the items it does not call for (staging scans, tumor markers, routine laboratory tests, radiation after mastectomy for node-negative disease, a bone-modifying agent at low fracture risk, and echocardiography without trastuzumab). One protocol deviation is recorded: baseline arm measurements for lymphedema were planned at the pre-anesthesia visit but not taken. The post-operative visit records this, with equal measurements that day showing no swelling was missed, and the corrective action. The germline result (no pathogenic variant) and the recurrence score (13) are reported in prose. They are not observations, because the testing laboratory and the surgical team ordered and reported them.
- **Consultation.** The breast surgery referral and the consultation by Gideon Marsh, MD (a fictional consultant), on the day of the second visit, are **S**. The consultant answers the five referral questions with what the record shows happened afterwards: MRI, which found a second focus that a biopsy confirmed; mastectomy with sentinel node biopsy for multicentric disease; germline testing before surgery; general anesthesia with a PECS II block and an opioid-sparing plan, with each step explained in advance; reconstruction offered, which she declined; and a recurrence score with a medical oncology review, which led to anastrozole with no chemotherapy and no radiation. The baseline arm measurements the consultant advised were missed, as recorded in the focused-visit deviation.
- **Not used.** Her later life and her death are recorded only as claims. Her husband's and son's own words in the letter, and their health, are not used. Her height is not recorded in a fetched source; the 160 cm in the record is synthetic.
- **Presenting concern.** The intake documents list the presenting concern (PRB-007) rather than the breast cancer, which is recorded from the biopsy-results visit. The presenting-concern problem is synthetic (**S**); it is resolved, superseded by the diagnosis, from that visit on.
- Burney died in 1840, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
